Revenue
2022
2023
2024
2025
Haoxi Health Technology Ltd (HAO)
Price—Loading quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $537,646 | $1.2M | $28.2M | $16.2M |
| Gross profit | $927,750 | $2.8M | $2.1M | $648,721 |
| Research & development | $79,544 | $79,985 | $58,161 | $102,524 |
| Operating expenses | $2.9M | $1.0M | $866,255 | $379,953 |
| Operating income | −$2.0M | $1.7M | $1.2M | $268,768 |
| EBITDAderived | −$1.6M | — | — | — |
| Net income | $3.9M | $1.3M | $969,752 | $244,587 |
| Basic EPSper diluted share | $1.66 | $1.06 | $0.87 | $0.01 |
| Diluted EPSper diluted share | $1.32 | $1.06 | $0.87 | $0.01 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 19, 2026Form 4 | Fan ZhenCEO & Chairman | BuyClass B Ordinary Shares | 40.00M | $0.02 | $800.0K | 40.69M |